The Leadbitter Group has been appointed by the University of Exeter to construct a £2m building for teaching and research to help improve the understanding and treatment of mood disorders. Located behind the Washington Singer building on the university's Streatham campus, the facility consists of a purpose-built treatment centre where clinical trials will be undertaken to evaluate psychological therapies. Professor Ed Watkins of the existing Mood Disorders Centre said "The state-of-the art laboratory facilities will help us study the underlying psychological mechanisms and inform the development of more targeted and effective therapies. The purpose-built treatment centre will allow us to conduct valuable clinical trials to determine which of these new treatments works best, as well as to improve existing treatments."
Leadbitter wins mental health bid
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Marketing
Design in Mental Health: Conversations that matter
Taking place on 2–3 June at Coventry Building Society Arena, the event brings together clinicians, estates professionals, architects, designers, policymakers, suppliers and lived experience experts to explore how better environments can support better mental health outcomes
Design & Build
Design for Change. Meet demand. Deliver safer and more therapeutic environments
As demand on mental health services continues to grow, the role of the built environment has never been more important. From inpatient wards and community hubs to sensory spaces and therapeutic landscapes, the environments in which care is delivered have a direct impact on patient recovery, staff wellbeing and operational effectiveness
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.